Given the blistering rate at which researchers of all stripes, academic and corporate, are accumulating data on the molecular nature of disease, applying those data in drug discovery efforts is a natural next step. But, even with plentiful data and computing power, multiple roadblocks to reducing the time, costs and productivity of discovery remain.